DC Healthcare Holdings Berhad (“DC Healthcare” or the “Group”), a medical aesthetic services provider specialising in the provision of non-invasive and minimally invasive procedures, today announced its financial results for the fourth quarter ended 31 December 2025 (“Q4 FY2025”), marking continued recovery with improved profitability and strong revenue growth.
The Group recorded revenue of RM21.91 million in Q4 FY2025, representing a 32% increase compared to RM16.61 million in the corresponding quarter last year (“Q4 FY2024”). Growth was primarily driven by stronger cash sales collection from aesthetic services, which contributed RM18.44 million or 84% of total revenue for the current quarter. The higher revenue translated into a higher gross profit of RM10.13 million, compared to RM8.21 million in Q4 FY2024.
DC Healthcare recorded a Profit Before Tax (“PBT”) of RM0.47 million in Q4 FY2025, a significant improvement from a Loss Before Tax (“LBT”) of RM3.24 million in Q4 FY2024. The turnaround was mainly attributable to higher gross profit as well as lower staff costs and administrative expenses incurred during the current quarter.
On a full-year basis, the Group recorded revenue of RM86.13 million for financial year ended 31 December 2025 (“FY2025”), representing a 54% increase compared to RM55.80 million in financial year ended 31 December 2024 (“FY2024”). Gross profit rose sharply to RM44.13 million from RM21.25 million previously, while the Group achieved a PBT of RM1.66 million for FY2025 compared to an LBT of RM20.42 million in FY2024, reflecting a meaningful turnaround in operational performance.
Quarter-on-quarter, revenue declined by 15% from RM25.72 million in Q3 FY2025 to RM21.91 million in Q4 FY2025 due to lower redemption rates for aesthetic services, which impacted gross profit and earnings for the current quarter. Despite this, the Group remained profitable, demonstrating resilience in its operating model.
Dr. Chong Tze Sheng, Managing Director of DC Healthcare commented, “FY2025 marks a significant milestone for DC Healthcare as we return to profitability while delivering strong revenue growth. The improvement reflects sustained demand for our aesthetic services, disciplined cost management, and better operational execution. We remain focused on strengthening our brand ecosystem, enhancing patient engagement, and expanding our clinic network to support future growth.”
Looking ahead, DC Healthcare continues to strengthen its strategic pillars to drive sustainable growth. The Group is synergising its core brands, Dr. Chong Clinic, Dr. Chong Slimming, and NewB Premium Skincare while expanding its skincare product offerings. The Group is also exploring artificial intelligence-assisted skin analysis and personalised treatment plans to enhance service precision and customer retention.
Additionally, to improve operational efficiency, DC Healthcare is implementing a Group-wide efficiency programme to streamline processes, optimise resource allocation, and improve cost control. An enterprise resource planning (“ERP”) system is also being introduced to support data-driven decision-making and operational scalability in the future.
With these initiatives underway, DC Healthcare is well-positioned to build on its recovery momentum and capture the growing opportunities in Malaysia’s aesthetic and wellness market.
